-
Clinical Ophthalmology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Case of endogenous endophthalmitis caused by Streptococcus equisimilis
Case report
(1653) Views (462) Full article downloads
Authors: Shinsuke Suemori, AkirA Sawada, Shinya Komori, et al
Published Date August 2010
Volume 2010:4 Pages 917 - 918
DOI: http://dx.doi.org/10.2147/OPTH.S10900
Shinsuke Suemori1, Akira Sawada1, Shinya Komori1, Kiyofumi Mochizuki1, Kiyofumi Ohkusu2, Hirofumi Takemura31Department of Ophthalmology, 2Department of Microbiology, 3Department of General and Cardiothoracic Surgery Gifu University Graduate School of Medicine, Gifu, Japan
Abstract: We report a rare case of endogenous endophthalmitis caused by Streptococcus equisimilis. A 74-year-old woman with endocarditis developed endogenous endophthalmitis. The patient underwent emergency mitral valvuloplasty, and intravitreal and subconjunctival injections of vancomycin and meropenem. After the surgery, she was treated with topical antibiotics, ointment, intravenous gentamicin and intravenous penicillin G potassium. The causative organism was identified as S. equisimilis. S. equisimilis should be considered as a pathogen that can cause severe endogenous endophthalmitis.
Keywords: endogenous endophthalmitis, group G Streptococcus, endocarditis, Streptococcus equisimilis
Other articles by Dr A Sawada
Case of endophthalmitis following intravitreal injections of bevacizumab- Journal Indexing
See where all the Dove Press journals are indexed
- Interested in being a peer-reviewer?
Click here to register.
- Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives
- Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
- A computer-based anaglyphic system for the treatment of amblyopia
- Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%




